NEW YORK (GenomeWeb News) – Helicos BioSciences today said that it will raise net proceeds of roughly $9.4 million through the sale of its common stock and warrants to certain existing investors through a private placement.

The Cambridge, Mass.-based maker of single-molecule sequencing systems said that the investors include venture capital investors Atlas Ventures, Flagship Ventures, Highland Capital Partners, Versant Ventures, and the firm's CEO, Ron Lowy.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.